GGrantIndex
Sort

23,748 grants matching melanoma

Immunotherapy with Dendritic-Allogeneic Tumor Cells

$313,650
Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA

Immunotherapy with Dendritic-Allogeneic Tumor Cells

$313,650
Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · CA

Neuroimmune Mechanisms of Depressive-Like Behavior During Aging

$313,650
Keith W. Kelley · University Of Illinois At Urbana-Champaign · R01 · FY2007 · AG

PDX Core

$313,602
Meenhard Herlyn · Wistar Institute · U54 · FY2020 · CA

PDX Core

$313,602
Meenhard Herlyn · Wistar Institute · U54 · FY2021 · CA

Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm

$313,533
Richard G Vile · Mayo Clinic Rochester · R01 · FY2009 · CA

Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm

$313,533
Richard G Vile · Mayo Clinic Rochester · R01 · FY2010 · CA

Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm

$313,533
Richard G Vile · Mayo Clinic Rochester · R01 · FY2008 · CA

IMPACT OF AICD ON TCR TRANSDUCED T CELLS FOR ADOPTIVE IMMUNOTHERAPY

$313,532
Michael I Nishimura · Loyola University Chicago · P01 · FY2014 · CA

Fibronectin Assembly, Structure and Function

$313,411
Jean E Schwarzbauer · Princeton University · R01 · FY2007 · CA

Fibronectin Assembly, Structure and Function

$313,411
Jean E Schwarzbauer · Princeton University · R01 · FY2008 · CA

Fibronectin Assembly, Structure and Function

$313,411
Jean E Schwarzbauer · Princeton University · R01 · FY2009 · CA

Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy

$313,408
Rajesh Agarwal · University Of Colorado Denver · R01 · FY2010 · CA

Mechanisms of Inhibitors of MRTF/SRF-regulated Gene Transcription

$313,381
Richard R Neubig · Michigan State University · R01 · FY2016 · GM

Prospective Study of the Associations between Cutaneous Papillomavirus and Polyo

$313,329
Dana Elise Rollison · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2017 · CA

Slit-Robo Signaling in Tumor Growth and Metastasis

$313,325
Jian-Guo Geng · University Of Michigan At Ann Arbor · R01 · FY2012 · CA

Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation

$313,325
Jose Alejandro Guevara-Patino · Loyola University Chicago · R01 · FY2016 · CA

Tumor Recognition by TCR Transduced CD4+ and CD8+T Cells

$313,325
University Of Chicago · R01 · FY2004 · CA

Akt3 Signaling as a Therapeutic Target

$313,325
Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2009 · CA

Tumor Recognition by TCR Transduced CD4+ and CD8+T Cells

$313,325
University Of Chicago · R01 · FY2003 · CA

Tumor Recognition by TCR Transduced CD4+ and CD8+T Cells

$313,325
University Of Chicago · R01 · FY2002 · CA

Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation

$313,325
Jose Alejandro Guevara-Patino · Loyola University Chicago · R01 · FY2014 · CA

Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation

$313,325
Jose Alejandro Guevara-Patino · Loyola University Chicago · R01 · FY2015 · CA

Slit-Robo Signaling in Tumor Growth and Metastasis

$313,325
Jian-Guo Geng · University Of Minnesota · R01 · FY2009 · CA

Tumor Recognition by TCR Transduced CD4+ and CD8+T Cells

$313,325
University Of Chicago · R01 · FY2001 · CA